Eupraxia Pharmaceuticals Inc
TSX:EPRX

Watchlist Manager
Eupraxia Pharmaceuticals Inc Logo
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Watchlist
Price: 5.35 CAD 1.33% Market Closed
Market Cap: 191.8m CAD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

EPRX Price Targets Summary
Eupraxia Pharmaceuticals Inc

Wall Street analysts forecast EPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EPRX is 10.33 CAD with a low forecast of 8.33 CAD and a high forecast of 12.6 CAD.

EPRX Lowest Forecast
Wall Street Target
8.33 CAD
56% Upside
EPRX Average Forecast
Wall Street Target
10.33 CAD
93% Upside
EPRX Highest Forecast
Wall Street Target
12.6 CAD
136% Upside
Lowest
Price Target
8.33 CAD
56% Upside
Average
Price Target
10.33 CAD
93% Upside
Highest
Price Target
12.6 CAD
136% Upside
Eupraxia Pharmaceuticals Inc Competitors:
Price Targets
VCEL
Vericel Corp
52% Upside
CSL
CSL Ltd
33% Upside
ADAG
Adagene Inc
482% Upside
AGIO
Agios Pharmaceuticals Inc
93% Upside
VCEL
Vericel Corp
52% Upside
CSL
CSL Ltd
33% Upside
ADAG
Adagene Inc
482% Upside
AGIO
Agios Pharmaceuticals Inc
93% Upside
AVTE
Aerovate Therapeutics Inc
11% Downside
DSGN
Design Therapeutics Inc
113% Upside
300009
Anhui Anke Biotechnology Group Co Ltd
25% Upside
ALGEN
Genoway SA
90% Upside

Revenue
Forecast

Revenue Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-23%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-26%
Average Miss
What are analyst estimates?

See Also

Summary
EPRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
EPRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EPRX stock valuation using valuation multiples.
Wall Street Estimates
EPRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EPRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EPRX's stock price target?
Price Target
10.33 CAD

According to Wall Street analysts, the average 1-year price target for EPRX is 10.33 CAD with a low forecast of 8.33 CAD and a high forecast of 12.6 CAD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 255,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.